Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

被引：0
|
作者：
Alice Indini
Lorenza Di Guardo
Carolina Cimminiello
Michele Prisciandaro
Giovanni Randon
Filippo De Braud
Michele Del Vecchio
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology
[2] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Department of Medical Oncology and Hematology
[3] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Università degli studi di Milano
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Melanoma; Immunotherapy; Anti-PD1; IrAEs; Vitiligo; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：511 / 521
页数：10
相关论文
共 50 条
  • [31] Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
    Delaney, Nicolas
    Michot, Jean-Marie
    Comont, Thibault
    Kramkimel, Nora
    Lazarovici, Julien
    Dupont, Romain
    Champiat, Stephane
    Chahine, Claude
    Robert, Caroline
    Herbaux, Charles
    Besse, Benjamin
    Guillemin, Aude
    Mateus, Christine
    Pautier, Patricia
    Saiag, Purippe
    Madonna, Enmauela
    Maerevoet, Marie
    Bout, Jeao-Christophe
    Leduc, Charlotte
    Biscay, Pascal
    Quere, Gilles
    Nardin, Charlee
    Ebbo, Mikael
    Albiges, Laurence
    Marret, Gregoire
    Levrat, Virginie
    Dujon, Cecile
    Vargaftig, Jacques
    Laghouati, Salim
    Croisille, Loure
    Voisin, Anne-Laure
    Godeau, Bertrand
    Massard, Christophe
    Ribrag, Vincent
    Marabelle, Aurellen
    Michel, Marc
    Lambotte, Olivier
    LANCET HAEMATOLOGY, 2019, 6 (01): : E48 - E57
  • [32] Immune-related adverse events correlate with improved survival in patients with advanced mucosal melanoma treated with nivolumab: A single-center retrospective study in Japan
    Otsuka, Masaki
    Sugihara, Satoru
    Mori, Shoichiro
    Hamada, Kengo
    Sasaki, Yosuke
    Yoshikawa, Shusuke
    Kiyohara, Yoshio
    JOURNAL OF DERMATOLOGY, 2020, 47 (04): : 356 - 362
  • [33] Impact of sex on immune-related adverse events in patients with melanoma
    Ottaviano, Margaret
    Mallardo, Domenico
    Vitale, Maria Grazia
    Vanella, Vito
    Fordellone, Mario
    Festino, Lucia
    Trojaniello, Claudia
    Sparano, Francesca
    Facchini, Bianca Arianna
    Cioli, Eleonora
    Isaja, Antonio
    Cavalcanti, Ernesta
    Capone, Mariaelena
    Madonna, Gabriele
    Paone, Miriam
    Chiodini, Paolo
    Caraco, Corrado
    Simeone, Ester
    Ascierto, Paolo Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases
    Huo, Cecilia W.
    Gunadasa, Indika
    Gkolia, Panagiota
    Shackleton, Mark
    Hunn, Martin
    MELANOMA RESEARCH, 2023, 33 (01) : 58 - 65
  • [35] Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy
    Narvaez, J.
    Juarez-Lopez, P.
    LLuch, J.
    Narvaez, J. A.
    Palmero, R.
    Garcia del Muro, X.
    Nolla, J. M.
    Domingo-Domenech, E.
    AUTOIMMUNITY REVIEWS, 2018, 17 (10) : 1040 - 1045
  • [36] Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy
    Finazzi, T.
    Rordorf, T.
    Ikenberg, K.
    Huber, G. F.
    Guckenberger, M.
    Schueler, H. I. Garcia
    BMC CANCER, 2018, 18
  • [37] Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
    Watson, Alexander S.
    Goutam, Siddhartha
    Stukalin, Igor
    Ewanchuk, Benjamin W.
    Sander, Michael
    Meyers, Daniel E.
    Pabani, Aliyah
    Cheung, Winson Y.
    Heng, Daniel Y. C.
    Cheng, Tina
    Monzon, Jose G.
    Navani, Vishal
    JAMA NETWORK OPEN, 2022, 5 (12) : E2245596
  • [38] Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy
    T. Finazzi
    T. Rordorf
    K. Ikenberg
    G. F. Huber
    M. Guckenberger
    H. I. Garcia Schueler
    BMC Cancer, 18
  • [39] Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies
    Rogado, Jacobo
    Romero-Laorden, Nuria
    Miguel Sanchez-Torres, Jose
    Maria Ramos-Levi, Ana
    Pacheco-Barcia, Vilma
    Isabel Ballesteros, Ana
    Arranz, Reyes
    Lorenzo, Alicia
    Gullon, Pedro
    Garrido, Ana
    Serra Lopez-Matencio, Jose Maria
    Donnay, Olga
    Adrados, Magdalena
    Costas, Pablo
    Aspa, Javier
    Alfranca, Arantzazu
    Mondejar, Rebeca
    Colomer, Ramon
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [40] Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients
    Kashiwada, Takeru
    Takano, Ryotaro
    Ando, Fumihiko
    Kuroda, Shoko
    Miyabe, Yoshishige
    Owada, Ryuji
    Miyanaga, Akihiko
    Asatsuma-Okumura, Tomoko
    Hashiguchi, Masaaki
    Kanazawa, Yoshikazu
    Yoshida, Hiroshi
    Seike, Masahiro
    Gemma, Akihiko
    Iwai, Yoshiko
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345